References

• Ahmed, T. A. (2015). Pharmacokinetics of Drugs Following IV Bolus, IV Infusion, and Oral Administration. Basic Pharmacokinetic Concepts and Some Clinical Applications
• Alavijeh, M. S., Chishty, M., Qaiser, M. Z., & Palmer, A. M. (2005). Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRX, 2(4), 554-571.
• Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997). Physiological Parameter Values for Physiologically Based Pharmacokinetic Models. Toxicology and Industrial Health, 13(4), 407-484.
• Carlander, U., Li, D., Jolliet, O., Emond, C., & Johanson, G. (2016). Toward a general physiologically based pharmacokinetic model for intravenously injected nanoparticles. International Journal of Nanomedicine, 625.
• Denti, P., Mirochnick, M., & Cressey, T. R. (n.d.). MODULE 2: PHARMACOKINETIC MODELLING ©Courtesy of Photoshare 38. Retrieved from website:
• DiStefano, J. J., & Landaw, E. M. (1984). Multiexponential, multicompartmental, and noncompartmental modeling. I. Methodological limitations and physiological interpretations. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 246(5), R651-R664.
• Dvorchik, B. H., & Vesell, E. S. (1976). Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clinical Chemistry, 22(6), 868-878.
• Holz, M. (2001). Compartment modeling. Advanced Drug Delivery Reviews, 48(2-3), 249-264.
• Jones, H. M., Parrott, N., Jorga, K., & Lave, T. (2006). A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics. Clinical Pharmacokinetics, 45(5), 511-542.
• ones, H., & Rowland-Yeo, K. (2013). Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development. CPT: Pharmacometrics & Systems Pharmacology, 2(8), e63.
• ok-Yong, S., & Lawrence, L. (2015). Drug Distribution and Drug Elimination. Basic Pharmacokinetic Concepts and Some Clinical Applications.
• MENGE, M., ROSE, M., BOHLAND, C., ZSCHIESCHE, E., KILP, S., METZ, W., ... NÜRNBERGER, M. (2011). Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). Journal of Veterinary Pharmacology and Therapeutics, 35(6), 550-559.
• Nestorov, I. A. (1998). Lumping of whole-body physiologically based pharmacokinetic models. Journal of Pharmacokinetics and Pharmacodynamics, 26(1), 21-46.
• Popović, J. K., Atanacković, M. T., Pilipović, A. S., Rapaić, M. R., Pilipović, S., & Atanacković, T. M. (2010). A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac. Journal of Pharmacokinetics and Pharmacodynamics, 37(2), 119-134.
• Prabu, S. L., Suriyaprakash, T. N. K., Ruckmani, K., & Thirumurugan, R. (2015). Biopharmaceutics and Pharmacokinetics. Basic Pharmacokinetic Concepts and Some Clinical Applications.
• Reddy, M. B., Iii, H. J. C., Lave, T., & Andersen, M. E. (2013). Physiologically Based Pharmacokinetic Modeling: A Tool for Understanding ADMET Properties and Extrapolating to Human. New Insights into Toxicity and Drug Testing.
• Rowland, M., Peck, C., & Tucker, G. (2011). Physiologically Based Pharmacokinetics in Drug Development and Regulatory Science. Annual Review of Pharmacology and Toxicology, 51(1), 45-73.
• Schlender, J.-F., Meyer, M., Thelen, K., Krauss, M., Willmann, S., Eissing, T., & Jaehde, U. (2016). Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Clinical Pharmacokinetics, 55(12), 1573-1589.
• Shuenn-Tsong Young, & Kuang-Ning Hsiao. (1994). A pharmacokinetic model to study administration of intravenous anaesthetic agents. IEEE Engineering in Medicine and Biology Magazine, 13(2), 263-268.
• Yamaoka, K., Nakagawa, T., & Uno, T. (1978). Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6(6), 547-558.